U.S. Diversified Financial Stock News

NYSE:FBP
NYSE:FBPBanks

First BanCorp (FBP) On Fresh Earnings Momentum And A Stock That Looks Fairly Valued

First BanCorp (FBP) drew fresh investor attention after reporting second quarter 2026 results, combining lower net charge offs of $15,979,000 with ongoing share repurchases and a reaffirmed quarterly dividend. See our latest analysis for First BanCorp. At a share price of $28.82, First BanCorp has posted a strong year to date share price return of 37.89%, with recent momentum supported by a 18.89% 90 day share price return and a 41.16% 1 year total shareholder return. If First BanCorp's...
NasdaqGS:IPGP
NasdaqGS:IPGPElectronic

Can IPG Photonics (IPGP) Trade At A Premium On Earnings?

IPG Photonics stock has declined by around 58.0% over the past five years, yet the shares still screen as expensive on the valuation checks that are available today. Over five years, IPG Photonics has fallen about 58.0%, which indicates that long term shareholders have faced a significant loss of value. The agreed €300 million acquisition of Lumibird Medical, with a potential €50 million earnout, can support expectations for a broader medical laser platform. However, integration and...
NasdaqGS:AMGN
NasdaqGS:AMGNBiotechs

Amgen (AMGN) Beat Revenue Forecasts, Is The Stock Overvalued?

Amgen (AMGN) is back in focus after quarterly revenue of $8.62b surpassed analyst forecasts, with management pointing to double digit growth across 16 brands and reaffirming confidence in its long term outlook. See our latest analysis for Amgen. Against this backdrop, Amgen’s recent momentum has been firm. A 10.54% 90 day share price return and a 26.34% 1 year total shareholder return suggest investors are responding positively to earnings delivery and the company’s pipeline progress. If you...
NasdaqGS:ACAD
NasdaqGS:ACADBiotechs

Is ACADIA Pharmaceuticals (ACAD) A Bargain On Fast Track News And Trial Timing?

ACADIA Pharmaceuticals (ACAD) drew investor attention after the FDA granted Fast Track designation to its investigational drug remlifanserin for hallucinations and delusions in Alzheimer’s disease psychosis, alongside new timing details for the RADIANT trial program. See our latest analysis for ACADIA Pharmaceuticals. The Fast Track news arrives after a period where ACADIA Pharmaceuticals’ share price has moved in fits and starts. The 90 day share price return of 11.39% contrasts with a year...
NasdaqGS:SKYW
NasdaqGS:SKYWAirlines

SkyWest (SKYW) Stock Faces Margin Decline That Tests Bullish Profitability Narratives

SkyWest (SKYW) has just put fresh numbers on the table for Q2 2026, reporting total revenue of US$1.1 billion and basic EPS of US$2.55, with net income of US$100.7 million setting the tone for the quarter. The company has seen quarterly revenue move from US$1.02 billion in Q4 2025 to US$1.01 billion in Q1 2026 and then to US$1.1 billion in Q2 2026, while quarterly EPS shifted from US$2.28 to US$2.54 to US$2.55 over the same stretch. This gives investors a clear view of how the top and bottom...
NasdaqGS:SPCX
NasdaqGS:SPCXTelecom

SpaceX (SPCX) Is Down 7.2% After Nasdaq‑100 Addition Amid Post‑IPO Volatility And Lock‑Up Jitters

In recent weeks, Space Exploration Technologies Corp. has been added to the Nasdaq‑100 Index, even as its shares continued to slide after June’s record‑setting IPO and ahead of its first earnings report on August 4, which will trigger initial insider lock‑up expirations on August 6. At the same time, operational and commercial developments, from Starship test delays to Cebu Pacific’s decision to introduce Starlink inflight Wi‑Fi, highlight how SpaceX’s heavy investment in launch,...
NasdaqGM:ACMR
NasdaqGM:ACMRSemiconductor

ACM Research (ACMR) Stock Could Be 46% Overvalued Despite Strong Growth Hopes

ACM Research stock has delivered a very large 3 year return while current valuation checks, including an intrinsic value estimate using a Discounted Cash Flow (DCF) approach and market multiples, both point to the shares trading at a premium. ACM Research has returned roughly 7x over the past 3 years. This puts extra focus on whether the current price leaves much margin for error. Expectations for future revenue and cash flow growth can support the current valuation. However, any...
NYSE:KTB
NYSE:KTBLuxury

Kontoor Brands (KTB) Stock Still Looks Reasonable Following Its 117% Run

Kontoor Brands has delivered a 117.0% gain over the past 3 years, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and earnings multiples still point to the stock trading at a discount to what the fundamentals suggest. Over 3 years, Kontoor Brands is up 117.0%, which puts recent valuation questions in the context of a strong longer term share price move. Recent earnings-related news can support confidence in revenue momentum, but the stock's pullback of 2.4% over the last...
NYSE:D
NYSE:DIntegrated Utilities

Is Dominion Energy (D) Fully Valued As Investors Look Ahead To June 2026 Earnings?

Dominion Energy (D) heads into its June 2026 earnings report with expectations for higher year-over-year earnings and revenues, while recent negative estimate revisions leave investors focused on the likelihood of an earnings beat. See our latest analysis for Dominion Energy. Dominion Energy's share price has climbed 13.76% over the past 90 days and 20.02% year to date to around $71.10, while its 1 year total shareholder return of 26.36% and 3 year total shareholder return of 53.59% point to...
NasdaqGS:ROCK
NasdaqGS:ROCKBuilding

Gibraltar Industries (ROCK) Could Be 34% Undervalued Ahead Of August 5 Results

Gibraltar Industries (ROCK) is preparing to release its second quarter 2026 results on August 5, a scheduled update that gives investors fresh information to reassess the stock’s recent performance and segment mix. See our latest analysis for Gibraltar Industries. At a share price of US$45.19, Gibraltar Industries has shown short term momentum, with a 7 day share price return of 4.65% and a 90 day share price return of 13.23%, set against a year to date share price decline of 9.87% and a 1...
NasdaqGS:GLXY
NasdaqGS:GLXYCapital Markets

Galaxy Digital (NasdaqGS:GLXY) Could Be 46% Undervalued Following $3.507b Texas Data Center Notes

Galaxy Digital (GLXY) stock is back in focus after the company priced $3.507b in secured notes through its Galaxy Helios Data Centers II unit to help fund a new data center project in Texas. See our latest analysis for Galaxy Digital. Against this backdrop of new data center financing and fresh institutional products, Galaxy Digital’s share price has been volatile, with the stock down 6.74% on the day and about 22.49% over 30 days, although its 3 year total shareholder return of over 7x...
NasdaqGS:CHKP
NasdaqGS:CHKPSoftware

Check Point Software Technologies (CHKP) Faces Mixed Valuation Views, Is The Stock Still Cheap?

Check Point Software Technologies (CHKP) stock is drawing attention after recent trading left it modestly higher over the past month but lower over the past 3 months and year to date, prompting closer scrutiny from investors. See our latest analysis for Check Point Software Technologies. At a share price of $130.57, Check Point Software Technologies has seen a 3.62% 1 day share price gain, but its year to date share price return is down 27.87%, while the 1 year total shareholder return has...
NasdaqGS:UAL
NasdaqGS:UALAirlines

Will Higher-End 2026 Guidance and Cabin Upgrades Change United Airlines' (UAL) Profitability Narrative?

Earlier this month, United Airlines Holdings tightened its full-year 2026 earnings guidance to the upper end of its prior range at US$9–US$11 per share and issued third-quarter 2026 guidance of US$2.50–US$3.50 per share, assuming an all-in fuel price of about US$3.69. United also unveiled new Economy Plus seating and premium cabin features on its upcoming Airbus A321XLR fleet, reinforcing its push to differentiate the travel experience on international short- to medium-haul routes. Next,...
NYSE:IDA
NYSE:IDAElectric Utilities

IDACORP (IDA) Declares Dividend, Is The Upside Already Priced In?

IDACORP (IDA) declared a common stock dividend of $0.88 per share, payable on August 31, 2026, to shareholders of record as of the close of business on August 5, 2026, drawing attention to its income profile. See our latest analysis for IDACORP. Against this dividend announcement, IDACORP’s latest share price of $148.57 sits after a modest pullback over the past month. Its year to date share price return of 16.71% and 1 year total shareholder return of 23.75% point to momentum that has built...
NYSE:AB
NYSE:ABCapital Markets

Is AllianceBernstein Holding (AB) Reasonable After A 49% Three Year Gain?

AllianceBernstein Holding stock has delivered a strong 48.6% gain over the past three years, yet today the valuation picture is more balanced. The Excess Returns intrinsic value estimate suggests the shares are roughly in line with fair value, while traditional market multiples lean towards the stock looking expensive. The 48.6% return over three years highlights that long term holders in AllianceBernstein Holding have already seen a solid payoff, which can reduce the margin of error for new...
NasdaqGM:ARDX
NasdaqGM:ARDXBiotechs

Ardelyx (ARDX) Faces A Valuation Test, Is The Discount Too Wide?

Why Ardelyx Stock Is Back in Focus Ardelyx (ARDX) is drawing fresh attention after recent market activity around its kidney disease and irritable bowel syndrome treatments, putting the stock under closer review for how the business fundamentals line up. See our latest analysis for Ardelyx. At a share price of US$5.03, Ardelyx has seen short term share price pressure, with the 30 day share price return down 9.37% and the year to date share price return down 18.21%. At the same time, the 1 year...
NYSE:DECK
NYSE:DECKLuxury

Deckers Outdoor (DECK) Is Down 9.8% After Record First Billion-Dollar Quarter And Higher EPS Guidance

Earlier this week, Deckers Outdoor reported first-quarter fiscal 2027 results with record sales of US$1,019.53 million and net income of US$129.97 million, while slightly lifting full-year earnings guidance and targeting operating margins just above 21.5%. The company’s guidance now assumes using roughly 80% of projected fiscal 2027 free cash flow for share repurchases, underscoring management’s focus on returning capital while brands like HOKA and UGG continue to power its more than US$5.86...
NasdaqGS:FHB
NasdaqGS:FHBBanks

First Hawaiian (FHB) Stock Sees Net Interest Margin Strength Reinforce Bullish Growth Narratives

First Hawaiian (FHB) opened Q2 2026 with total revenue of US$225.7 million and basic EPS of US$0.60, backed by net income of US$73.4 million, setting a clear snapshot of recent performance. Over recent quarters the company has seen revenue move from US$213.0 million in Q2 2025 to US$218.2 million in Q4 2025 and then to US$225.7 million in Q2 2026. EPS shifted from US$0.58 to US$0.57 and then to US$0.60, giving investors a clean read on both top line and per share earnings trends as they weigh...
NYSE:WEX
NYSE:WEXDiversified Financial

WEX (WEX) Balances Buybacks And Product Expansion: What Does Its Higher 2026 Guidance Really Signal?

Earlier this week, WEX Inc. reported second-quarter 2026 results showing revenue of US$753.5 million and higher net income and earnings per share than a year ago, and it raised its full-year 2026 revenue guidance to a range of US$2.86 billion to US$2.90 billion while issuing third-quarter guidance of US$733 million to US$753 million. The company also completed a US$93 million buyback covering 642,768 shares, and entered a new agreement embedding Bluon’s HVAC intelligence into WEX Field...
NYSE:AGX
NYSE:AGXConstruction

Is Argan (AGX) Undervalued Or Has Its Power Infrastructure Story Already Been Priced In?

Argan (AGX) is back on investor radars after fresh attention on its role in power generation engineering, procurement, and construction services across the United States, the Republic of Ireland, and the United Kingdom. See our latest analysis for Argan. Recent trading has been choppy for Argan, with the share price down 5.54% over the last day and 25.68% over the past month. However, it is still showing a 74.54% year to date share price return and a very large 3 year total shareholder...
NasdaqGS:ALNY
NasdaqGS:ALNYBiotechs

Alnylam Pharmaceuticals (ALNY) Could Be 38% Undervalued After Mivelsiran Trial Progress

Alnylam Pharmaceuticals (ALNY) is in focus after presenting new mivelsiran data and trial updates at the Alzheimer’s Association International Conference, spotlighting its RNAi approach across multiple Alzheimer’s and cerebral amyloid angiopathy programs. See our latest analysis for Alnylam Pharmaceuticals. These Alzheimer’s and cerebral amyloid angiopathy updates land at a time when Alnylam Pharmaceuticals’ 1-year total shareholder return has declined 17.35%, while the 3-year and 5-year...
NYSE:VZ
NYSE:VZTelecom

Verizon (VZ) Stock Faces Margin Squeeze As 11.6% Net Profits Challenge Bullish Narrative

Verizon Communications (VZ) opened Q2 2026 with total revenue of US$34.3 billion and basic EPS of US$0.92 on net income of US$3.8 billion, setting a clear snapshot for how the business is currently earning its cash. Over recent quarters the company has seen revenue move around the low US$30 billions, from US$34.5 billion and EPS of US$1.18 in Q2 2025 to US$36.4 billion and EPS of US$0.55 in Q4 2025, before landing at US$34.3 billion and EPS of US$0.92 this quarter. This gives investors a...
NasdaqCM:KARO
NasdaqCM:KAROSoftware

Is Karooooo (KARO) Undervalued As It Reaffirms FY2027 Guidance?

Why Karooooo’s Latest Guidance Matters for Investors Karooooo (KARO) reaffirmed its fiscal 2027 earnings guidance, projecting subscription revenue of ZAR 5,700 million to ZAR 6,000 million and an operating margin of 27% to 30%, alongside higher guided EPS. This confirmation followed first quarter results to May 31, 2026, where Karooooo reported ZAR 1,563.95 million in sales and ZAR 294.26 million in net income, with basic EPS from continuing operations at ZAR 9.53. See our latest analysis for...
NYSE:NSC
NYSE:NSCTransportation

Norfolk Southern (NSC) Faces A 3% Above Fair Value View As Record Q2 Revenue Lands

Norfolk Southern (NSC) is back in focus after reporting second quarter 2026 results that combined record railway operating revenue with softer net income and earnings per share, prompting investors to reassess the stock’s risk reward profile. See our latest analysis for Norfolk Southern. Norfolk Southern’s recent Q2 update appears to be reinforcing positive sentiment, with a 12.10% 1 month share price return and 21.83% year to date share price return, while the 5 year total shareholder return...